ストックスクリーナーアプリを入手
2.76
0.72%
-0.02
アフターアワーズ：
2.76
前日終値:
$2.78
開ける：
$2.77
24時間の取引高:
1.24M
Relative Volume:
0.94
時価総額：
$435.66M
収益：
$10.00M
当期純損益:
$-29.47M
株価収益率:
-13.80
EPS:
-0.2
ネットキャッシュフロー:
$-21.55M
1週間 パフォーマンス:
+0.73%
1か月 パフォーマンス:
+18.97%
6か月 パフォーマンス:
-26.20%
1年 パフォーマンス:
-30.83%
1日の値動き範囲:
$2.72
$2.81
1週間の範囲:
$2.60
$2.85
52週間の値動き範囲:
$1.575
$5.02
Mereo Biopharma Group Plc Adr Stock (MREO) Company Profile
名前
Mereo Biopharma Group Plc Adr
セクター
電話
4403330237300
住所
ONE CAVENDISH PLACE, LONDON
MREO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MREO
Mereo Biopharma Group Plc Adr
|
2.76 | 435.66M | 10.00M | -29.47M | -21.55M | -0.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.45 | 115.69B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
529.24 | 53.25B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
307.99 | 39.22B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
577.89 | 35.78B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
269.63 | 27.68B | 3.81B | -644.79M | -669.77M | -6.24 |
Mereo Biopharma Group Plc Adr Stock (MREO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-27 | 開始されました | JP Morgan | Overweight |
| 2024-12-06 | 開始されました | Jefferies | Buy |
| 2024-06-13 | 開始されました | Robert W. Baird | Outperform |
| 2023-10-13 | 再開されました | BTIG Research | Buy |
| 2022-08-12 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-05-05 | 開始されました | BTIG Research | Buy |
| 2021-04-05 | 開始されました | Needham | Buy |
すべてを表示
Mereo Biopharma Group Plc Adr (MREO) 最新ニュース
SEC Form N-CSRS filed by abrdn World Healthcare Fund Shares of Beneficial Interest - Quantisnow
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), ACADIA Pharmaceuticals (ACAD) and Quanterix (QTRX) - The Globe and Mail
Mereo Biopharma Group Plc ADR (NASDAQ: MREO) Stock Sentiment: What’s Wall Street Saying? - Stocksregister
Analysts Offer Insights on Healthcare Companies: Organon (OGN), Diamedica Therapeutics (DMAC) and Nkarta (NKTX) - The Globe and Mail
Mereo BioPharma Group plc SEC 10-Q Report - TradingView
Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights - GlobeNewswire
Mereo Biopharma Group Plc ADR (MREO) can make a big difference with a little luck - Sete News
Analyzing Mereo Biopharma Group Plc ADR (MREO) After Recent Trading Activity - knoxdaily.com
How should investors view Mereo Biopharma Group Plc ADR (MREO)? - uspostnews.com
Analytical Overview: Mereo Biopharma Group Plc ADR (MREO)’s Ratios Tell a Financial Story - DWinneX
Balance Sheet Insights: Halliburton Co (HAL)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX
INN’s latest rating updates from top analysts. - knoxdaily.com
EVLV’s 2023 Market Dance: Down -10.63% – Time to Invest? - investchronicle.com
Mereo Biopharma Group Plc ADR: Buy, Hold, or Sell? Analysts Weigh In Amid Market Challenges - investchronicle.com
Mereo Biopharma Group Plc ADR [MREO] Shares Fall -0.78 % on Thursday - knoxdaily.com
Brookdale Senior Living Inc [BKD] Records 50-Day SMA of $5.84 - knoxdaily.com
VST Stock Sees Surge of Approximately 7.21% in Last Five Days - knoxdaily.com
Core & Main Inc [NYSE: CNM] Sees Increase in Stock Value - knoxdaily.com
This trade activity should not be overlooked: Mereo Biopharma Group Plc ADR (MREO) - Sete News
Financial Metrics Check: B. Riley Financial Inc (RILY)’s Ratios for Trailing Twelve Months - DWinneX
Mereo Biopharma Group Plc ADR [MREO] Investment Appeal on the Rise - knoxdaily.com
Freeport-McMoRan Inc [FCX] Stock sold by Insider Robertson Maree E. for $0.58 million - knoxdaily.com
D.R. Horton Inc (DHI) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Insider Sale Alert: Genworth Financial Inc [GNW] – Is it Time to sell? - knoxdaily.com
Mereo Biopharma Group Plc ADR (MREO) requires closer examination - uspostnews.com
SMX (Security Matters) Plc (SMX) shows promising results - uspostnews.com
Should investors be concerned about Uranium Energy Corp (UEC)? - uspostnews.com
Is Aquestive Therapeutics Inc (AQST) worth investing in despite its overvalued state? - uspostnews.com
Are Dave & Buster’s Entertainment Inc (PLAY) shares a good deal now? - uspostnews.com
EOLS Stock Sees Decline of Approximately -17.34% in Last Five Days - knoxdaily.com
There is no way Allarity Therapeutics Inc (ALLR) can keep these numbers up - Sete News
Mereo BioPharma stock hits 52-week low at $2.1 amid market challenges By Investing.com - Investing.com South Africa
Mereo BioPharma stock hits 52-week low at $2.1 amid market challenges - Investing.com India
C3is Inc Inc. (CISS) Price Performance Over the Years: A Comparative Study - investchronicle.com
Microchip Technology, Inc [MCHP] Stock sold by Insider Bjornholt James Eric for $0.23 million - knoxdaily.com
Mereo BioPharma’s SWOT analysis: rare disease stock poised for breakthrough - Investing.com India
Mereo BioPharma’s SWOT analysis: rare disease stock poised for breakthrough By Investing.com - Investing.com South Africa
Mereo BioPharma stock hits 52-week low at $2.25 - Investing.com India
Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights - GlobeNewswire
Mereo BioPharma Secures 3-Year Cash Runway While Pushing Phase 3 Studies Forward - Stock Titan
Closing Bell Recap: WANG & LEE Group Inc (WLGS) Ends at 0.43, Reflecting a -42.70 Downturn - The Dwinnex
Pfizer to Exit Sensodyne-Maker Haleon With Final Stake Sale - MSN
MEREO BIOPHARMA (MREO) Upgraded to Buy: What Does It Mean for the Stock? - MSN
ARS Pharmaceuticals outlines 2025 growth strategy with neffy commercialization and global expansion - MSN
Mereo BioPharma’s SWOT analysis: setrusumab, alvelestat drive rare disease stock potential - Investing.com India
Hidden Gems: 5 Stocks Under $10 With Massive Growth Potential - Barchart
How Do Things Look For Mereo Biopharma Group Plc ADR (NASDAQ: MREO) In The Short-Term? - Stocks Register
Mereo BioPharma stock hits 52-week low at $2.52 By Investing.com - Investing.com South Africa
Mereo BioPharma stock hits 52-week low at $2.52 - Investing.com India
Prepare Yourself for Liftoff: Mereo Biopharma Group Plc ADR (MREO) - SETE News
There is no doubt that OrganiGram Holdings Inc (OGI) ticks all the boxes. - SETE News
Mereo Biopharma Group Plc Adr (MREO) 財務データ
収益
当期純利益
現金流量
EPS
1.91%
1.17%
大文字化:
|
ボリューム (24 時間):